The Veteran's claim for service connection for acute myelogenous leukemia (AML) is denied as the evidence does not support a finding that AML was incurred or caused by any aspect of his active service, including exposure to herbicides.
The deciding factor: VA medical opinions found that AML was not related to service or to herbicide exposure and offered no additional probative value regarding its etiology.
- Claimed conditions
- Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- April 22, 2016
- Citation
- 1616240
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 1616240.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has determined that the Veteran's cause of death, Acute Myelogenous Leukemia (AML), is related to his in-service exposure to herbicide agents. After considering all evidence and resolving all reasonable doubt in favor of the claimant, service connection for AML due to herbicide exposure is granted.
- Whole decision: Denied
The Board denied the veteran's claims for an initial compensable rating for hypertension and a higher disability evaluation for MDS, as well as remanded service connection claims for bilateral hearing loss and tinnitus.
- Whole decision: Granted
The Board granted service connection for Myelodysplastic Syndrome, Prostate Cancer, Thyroid Cancer, and Parkinson's Disease based on new and relevant evidence of exposure to toxic chemicals during active service.
- Whole decision: Remanded (sent back)
The Board remands the case to obtain a TERA analysis and potentially an opinion regarding the Veteran's AML or MDS as it may be related to toxic exposure during service.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.